Stephen D. Hauschka

University of Washington, Seattle, Seattle, WA 
Skeletal muscle
"Stephen Hauschka"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Birch SM, Lawlor MW, Conlon TJ, et al. (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815
Bengtsson NE, Crudele JM, Klaiman JM, et al. (2022) Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model. Molecular Therapy : the Journal of the American Society of Gene Therapy
Bengtsson NE, Tasfaout H, Hauschka SD, et al. (2020) Dystrophin gene editing stability is dependent on dystrophin levels in skeletal but not cardiac muscles. Molecular Therapy : the Journal of the American Society of Gene Therapy
Kwon JB, Ettyreddy AR, Vankara A, et al. (2020) Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy. Methods & Clinical Development. 19: 320-329
Kolwicz SC, Hall JK, Moussavi-Harami F, et al. (2019) Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate. Jacc. Basic to Translational Science. 4: 778-791
Ramos JN, Hollinger K, Bengtsson NE, et al. (2019) Development of Novel Micro-dystrophins with Enhanced Functionality. Molecular Therapy : the Journal of the American Society of Gene Therapy
Tawara N, Yamashita S, Kawakami K, et al. (2018) Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. Experimental Neurology
Murray J, Odom G, Olafsson S, et al. (2018) AAV-Mediated Delivery of Ribonucleotide Reductase and Microdystrophin Rescues Function in Dystrophic Mice Biophysical Journal. 114: 541a
Amoasii L, Long C, Li H, et al. (2017) Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Science Translational Medicine. 9
Bengtsson NE, Hall JK, Odom GL, et al. (2017) Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 16007
See more...